News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Naveen Pemmaraju shares new report on oral DAC+VEN for BPDCN published in Leukemia and Lymphoma Journal
Naveen Pemmaraju and Hannah Goulart
May 6, 2025, 17:55

Naveen Pemmaraju shares new report on oral DAC+VEN for BPDCN published in Leukemia and Lymphoma Journal

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared an article co-authored by Hannah Goulart et al. on LinkedIn:

“Delighted to share our brand new original report  just published in Leukemia and Lymphoma, led by Dr Hannah Goulart and Dr Naveen Pemmaraju, MD oral DAC+VEN for patients with BPDCN”

Title: A case series of oral decitabine–cedazuridine with venetoclax for blastic plasmacytoid dendritic cell neoplasm

Journal: Leukemia and Lymphoma

Authors: Hannah Goulart, Guillermo Garcia-Manero, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Farhad Ravandi, Muzaffar Qazilbash, Caitlin Rausch, Gabriela Llaurador Caraballo, Sherry Pierce, Naveen Pemmaraju

Read the full article.

Naveen Pemmaraju

Learn more about blastic plasmacytoid dendritic cell neoplasm on OncoDaily.

Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN Caitlin Rausch cancer Courtney D. DiNardo Farhad Ravandi Gabriela Llaurador Caraballo Guillermo Garcia-Manero Hannah Goulart MD Anderson Cancer Center Muzaffar Qazilbash Naval Daver Naveen Pemmaraju OncoDaily Oncology Sherry Pierce Tapan M. Kadia
Special Coverage
Blog Posts
Aug 18, 2025, 20:57
Niranjala Siriwardena: Why I’m Fighting for Australia’s First Workplace Cancer Survivorship Policy
Voices
Aug 18, 2025, 20:47
Wafaa M Rashed: Final Words to the Tenth Cohort of the Policy Advocacy in Genetics and Genomics Course
Blog Posts
Aug 18, 2025, 20:36
Gashaw Arega: The Beginning of Childhood Cancer Care in Ethiopia
Opinion
Aug 18, 2025, 20:22
Soumen Das: From LMIC to LRS - Rethinking Global Health
Health Policy
Aug 18, 2025, 20:12
Niranjala Siriwardena: Building Australia’s First Workplace Cancer Survivorship Policy
Voices
Aug 18, 2025, 20:02
Confronting Stigma at the Crossroads of Hepatitis and Cancer - European Cancer Organisation
Positive
Aug 18, 2025, 19:53
Erin and Chloe Raise £800 for Lung Cancer Research - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 19:28
Liz O’Riordan: Everything You Need to Know about Breast Cancer Recurrence
Blog Posts
Aug 18, 2025, 19:17
Matteo Bauckneht: Pitfalls in PSMA-Based RLT - A Case-Based Review at EANM25
Insight
Aug 18, 2025, 18:55
NCODA Brings the BREAKWATER Trial into Practice
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer